Advertisement
Review Article| Volume 38, ISSUE 1, P91-100, March 2018

Lymphoma and Pathology in Sub-Saharan Africa

Current Approaches and Future Directions
Published:December 12, 2017DOI:https://doi.org/10.1016/j.cll.2017.10.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gopal S.
        • Wood W.A.
        • Lee S.J.
        • et al.
        Meeting the challenge of hematologic malignancies in sub-Saharan Africa.
        Blood. 2012; 119: 5078-5087
        • Gopal S.
        • Krysiak R.
        • Liomba N.G.
        • et al.
        Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses.
        PLoS One. 2013; 8: e70361
      1. Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed December 14, 2015.

        • Rogena E.A.
        • De Falco G.
        • Schurfeld K.
        • et al.
        A review of the trends of lymphomas in the equatorial belt of Africa.
        Hematol Oncol. 2011; 29: 111-115
        • Sinfield R.L.
        • Molyneux E.M.
        • Banda K.
        • et al.
        Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998-2003.
        Pediatr Blood Cancer. 2007; 48: 515-520
        • Moormann A.M.
        • Bailey J.A.
        Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.
        Curr Opin Virol. 2016; 20: 78-84
        • Montgomery N.D.
        • Liomba N.G.
        • Kampani C.
        • et al.
        Accurate real-time diagnosis of lymphoproliferative disorders in Malawi through clinicopathologic teleconferences: a model for pathology services in sub-Saharan Africa.
        Am J Clin Pathol. 2016; 146: 423-430
        • Engels E.A.
        • Pfeiffer R.M.
        • Goedert J.J.
        • et al.
        Trends in cancer risk among people with AIDS in the United States 1980-2002.
        AIDS. 2006; 20: 1645-1654
        • Pui C.H.
        • Relling M.V.
        • Downing J.R.
        Acute lymphoblastic leukemia.
        N Engl J Med. 2004; 350: 1535-1548
        • Pui C.H.
        • Sandlund J.T.
        • Pei D.
        • et al.
        Results of therapy for acute lymphoblastic leukemia in black and white children.
        JAMA. 2003; 290: 2001-2007
        • Wabinga H.R.
        • Nambooze S.
        • Amulen P.M.
        • et al.
        Trends in the incidence of cancer in Kampala, Uganda 1991-2010.
        Int J Cancer. 2014; 135: 432-439
        • Gopal S.
        • Fedoriw Y.
        • Kaimila B.
        • et al.
        CHOP chemotherapy for aggressive non-Hodgkin lymphoma with and without HIV in the antiretroviral therapy era in Malawi.
        PLoS One. 2016; 11: e0150445
        • Silverberg M.J.
        • Lau B.
        • Achenbach C.J.
        • et al.
        Cumulative incidence of cancer among persons with HIV in North America: a cohort study.
        Ann Intern Med. 2015; 163: 507-518
        • Msyamboza K.P.
        • Dzamalala C.
        • Mdokwe C.
        • et al.
        Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry.
        BMC Res Notes. 2012; 5: 149
        • Gota V.
        • Karanam A.
        • Rath S.
        • et al.
        Population pharmacokinetics of Reditux, a biosimilar rituximab, in diffuse large B-cell lymphoma.
        Cancer Chemother Pharmacol. 2016; 78: 353-359
      2. Rituximab plus CHOP chemotherapy for diffuse large B-cell lymphoma. Available at: https://clinicaltrials.gov/ct2/show/NCT02660710. Accessed August 22, 2017.

        • Gopal S.
        • Liomba N.G.
        • Montgomery N.D.
        • et al.
        Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
        J Int AIDS Soc. 2015; 18: 20122
        • Gopal S.
        • Fedoriw Y.
        • Montgomery N.D.
        • et al.
        Multicentric Castleman's disease in Malawi.
        Lancet. 2014; 384: 1158
        • Westmoreland K.D.
        • Montgomery N.D.
        • Stanley C.C.
        • et al.
        Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
        Int J Cancer. 2017; 140: 2509-2516
        • Morgan E.
        • Sweeny M.P.
        • Tomoka T.
        • et al.
        Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities.
        Blood Adv. 2016; 1: 84-92
        • Gopal S.
        Moonshot to Malawi.
        N Engl J Med. 2016; 374: 1604-1605
        • de Witt P.
        • Maartens D.J.
        • Uldrick T.S.
        • et al.
        Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South Africa.
        J Acquir Immune Defic Syndr. 2013; 64: 66-73
        • Bateganya M.H.
        • Stanaway J.
        • Brentlinger P.E.
        • et al.
        Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.
        J Acquir Immune Defic Syndr. 2011; 56: 312-319
        • Westmoreland K.D.
        • Stanley C.C.
        • Montgomery N.D.
        • et al.
        Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: longitudinal results from the Kamuzu Central Hospital lymphoma study.
        Pediatr Blood Cancer. 2017; 64https://doi.org/10.1002/pbc.26302
        • Harif M.
        • Barsaoui S.
        • Benchekroun S.
        • et al.
        Treatment of B-cell lymphoma with LMB modified protocols in Africa–report of the French-African Pediatric Oncology Group (GFAOP).
        Pediatr Blood Cancer. 2008; 50: 1138-1142
        • Stanley C.C.
        • Westmoreland K.D.
        • Heimlich B.J.
        • et al.
        Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi.
        Br J Haematol. 2016; 173: 705-712
        • Molyneux E.
        • Schwalbe E.
        • Chagaluka G.
        • et al.
        The use of anthracyclines in the treatment of endemic Burkitt lymphoma.
        Br J Haematol. 2016; https://doi.org/10.1111/bjh.14440
        • Buckle G.
        • Maranda L.
        • Skiles J.
        • et al.
        Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: a historical cohort study.
        Int J Cancer. 2016; 139: 1231-1240
        • Adesina A.
        • Chumba D.
        • Nelson A.M.
        • et al.
        Improvement of pathology in sub-Saharan Africa.
        Lancet Oncol. 2013; 14: e152-e157
        • Stefan D.C.
        Childhood cancer in Africa: an overview of resources.
        J Pediatr Hematol Oncol. 2015; 37: 104-108
        • Naresh K.N.
        • Raphael M.
        • Ayers L.
        • et al.
        Lymphomas in sub-Saharan Africa–what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?.
        Br J Haematol. 2011; 154: 696-703
        • Mpunga T.
        • Tapela N.
        • Hedt-Gauthier B.L.
        • et al.
        Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settings.
        Am J Clin Pathol. 2014; 142: 541-545
        • Mwanda W.O.
        • Orem J.
        • Fu P.
        • et al.
        Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
        J Clin Oncol. 2009; 27: 3480-3488
      3. Intravenous chemotherapy or oral chemotherapy in treating patients with previously untreated stage III-IV HIV-associated non-Hodgkin lymphoma. Available at: https://clinicaltrials.gov/ct2/show/NCT01775475. Accessed August 22, 2017.

        • Ngoma T.
        • Adde M.
        • Durosinmi M.
        • et al.
        Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
        Br J Haematol. 2012; 158: 749-762
        • Hesseling P.B.
        • Molyneux E.
        • Tchintseme F.
        • et al.
        Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana.
        Lancet Oncol. 2008; 9: 512-513
        • Schroeder L.F.
        • Amukele T.
        Medical laboratories in sub-Saharan Africa that meet international quality standards.
        Am J Clin Pathol. 2014; 141: 791-795
        • Kibet E.
        • Moloo Z.
        • Ojwang P.J.
        • et al.
        Measurement of improvement achieved by participation in international laboratory accreditation in sub-Saharan Africa: the Aga Khan University Hospital Nairobi experience.
        Am J Clin Pathol. 2014; 141: 188-195
        • Amukele T.K.
        • Michael K.
        • Hanes M.
        • et al.
        External quality assurance performance of clinical research laboratories in sub-Saharan Africa.
        Am J Clin Pathol. 2012; 138: 720-723
        • Gershy-Damet G.M.
        • Rotz P.
        • Cross D.
        • et al.
        The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.
        Am J Clin Pathol. 2010; 134: 393-400